Ignacio I. Wistuba, MD
Oncologist and Professor Ignacio I. Wistuba, MD, of The University of Texas MD Anderson Cancer Center, has been recognized by the International Association for the Study of Lung Cancer (IASLC) with a Distinguished Award at the IASLC 19th World Conference on Lung Cancer (WCLC) in Toronto. Dr. Wistuba was honored with the Mary J. Matthews Pathology/Translation Research Award, celebrating his lifetime scientific achievements in pathology/translational research in thoracic malignancies.
Dr. Wistuba is Chair of the Department of Translational Molecular Pathology, Division of Pathology/Lab Medicine, and is jointly appointed as Professor in the Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center. His research interests include explaining molecular abnormalities involved in the pathogenesis and evolution of lung cancer as well as identifying new molecular targets and validating biomarkers for targeted therapy.
A molecular pathology and surgical specialist with a robust record of scientific achievement, Dr. Wistuba has written 400 peer-reviewed articles and multiple book chapters. Additionally, he is a member of The University of Texas Graduate School of Biomedical Sciences, the MD Anderson Cancer Center Vice Provost Advisory Council on Clinical Research, and the MD Anderson Cancer Center Sister Institution Network Fund Committee. He is also a pathology liaison with the MD Anderson Cancer Center Institute for Personalized Cancer Therapy. ■
